Dendrimers for biomedical applications
2022 Activity indicators
- 1 European H2020 project: M-ERA.NET 2 (BIOMAG-6211).
- 7 competitive public projects (ISCIII, MICINN, CAM, CAM-UAH).
- 5 competitive intramural projects led (FUAH, FIBioHRC-FUAH).
- 8 competitive HR contracts
- 18 publications
- IF: 119.13
- Publications in Q1: 13 (72%)
- 1 supervised doctoral thesis read.
- 2 knowledge transfer awards
- Evaluator of projects in European and national public institutions: 2 and 3 PIs.
- Member of editorial committees: 3 researchers.
- 3 months stay in foreign centres:
- Faculty of Biology and Environmental Protection for interdisciplinary research and innovation of the University of Lodz (Poland).
- Institute of Organic Synthesis and Photoreactivity of the ltalian National Research Council, Bologna (ltaly)
- 1 patent application (P202131056): "Hydrogels with dendritic domains of carbosilane nature, their preparation and uses".
Milestones
-
Organisation of the VIII edition of the Dendrimers Meeting (EDEN VIII) held in person on 30-31 May 2022 in Alcalá de Henares.
-
Incorporation of 6 Predoctoral researchers (5 FPI-UAH and 1 FPI-Ministry).
-
Accesit granted to the patent "Magnetic nanoparticles stabilised with carbosilane dendritic systems and their uses". Call 2022 of the University of Alcalá Award for the Best National Patent.
-
Award obtained with the patent: "Metallodendrimers of carbosilane nature containing ruthenium and copper coordinated to Schiff base ligands, their preparation and uses" in the Patent of a woman inventor category of the SPTO 2022 awards.
-
Promotion of Dr. Matilde Alique to tenured university lecturer through the "Excellence for University Teaching Staff" action line of the University of Alcalá".
Bibliometrics
ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
---|---|---|---|---|---|---|---|
2018 | 5 | 19,80 | 3,96 | 5 | 100 | 1 | 20 |
2019 | 20 | 88,94 | 4,45 | 19 | 95 | 1 | 5 |
2020 | 32 | 141,92 | 4,43 | 32 | 100 | 4 | 13 |
2021 | 16 | 83,21 | 5,20 | 15 | 94 | 3 | 19 |
2022 | 18 | 119,13 | 6,62 | 18 | 100 | 3 | 17 |
91 | 453 | 4,93 | 89 | 98 | 12 | 13 |
* Only original articles, editorial material, guidelines and reviews.